Clinical Trials on Pediatric Infectious Disease in Germany

Total 21907 results

IRCCS Burlo Garofolo

Recruiting

Defects of Keratinocytes Function in Dermatologic Patients

Hidradenitis Suppurativa

Italy, Germany, Austria, Belgium, France, Slovenia
B. Braun Melsungen AG
CeGaT GmbH

Completed

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Germany
CureVac
German Federal Ministry of Education and Research

Completed

A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Germany
University of Cologne

Unknown

Endocarditis Registry of the University Hospital of Cologne (ER-UHC)

Infective Endocarditis

Germany
Harding Center for Risk Literacy

Recruiting

Equity Evaluation of Fact Boxes on Informed COVID-19 and Influenza Vaccination Decisions - Study Protocol

COVID-19 | Influenza

Germany
University of Cologne

Completed

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

HIV Infections | Acquired Immunodeficiency Syndrome

Germany
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above

Influenza

Germany
Robert Koch Institut

Completed

Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza

Influenza

Germany
University Hospital Tuebingen

Not yet recruiting

Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)

COVID-19 | ARDS

Germany
Technische Universität Dresden

Completed

Kinetics of Etheric Oils, Smart Textiles vs. Ointment

Common Cold

Germany
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents

Hepatitis B

Germany
Bayer

Completed

Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder

Pulmonary Disease, Chronic Obstructive | Infection

Germany
CSL Behring

Completed

Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis

Hidradenitis Suppurativa | Palmoplantar Pustulosis

Denmark, Australia, Germany
Hendrik Streeck
Federal Ministry of Health, Germany; US Military HIV Research Program; German... and other collaborators

Completed

HIV and STIs Clinical Study in Germany

HIV Infections | Sexual Behavior | Risk Reduction

Germany
University Hospital Tuebingen

Completed

Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children (Coro-Buddy)

Severe Acute Respiratory Syndrome

Germany
University Hospital Goettingen
Universitätsklinikum Hamburg-Eppendorf; University Hospital, Aachen; Transplantationszentrum...

Completed

Predict Adverse Events by Covid-19 Nephritis

Covid-19

Germany
ModernaTX, Inc.

Completed

Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects

Influenza

Germany
Charite University, Berlin, Germany
Hoffmann-La Roche

Completed

Oseltamivir Infant Influenza Safety Study

Influenza, Human

Germany
Novartis Vaccines

Completed

Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects

Influenza

Germany
GlaxoSmithKline

Completed

Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

Influenza

Germany
Vakzine Projekt Management GmbH

Completed

Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers

Healthy | Tuberculosis

Germany
Universitätsklinikum Hamburg-Eppendorf
King's College Hospital NHS Trust

Recruiting

Multicentre Study to Record the Mental and Physical Effects of the COVID-19 Pandemic (COBESITY-Study)

Overweight and Obesity | COVID-19 Pandemic

Germany
Pfizer
Innovative Medicines Initiative (IMI) COMBACTE-CARE

Completed

Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)

Complicated Intra-Abdominal Infections, cIAIs

Spain, France, Germany
Infectopharm Arzneimittel GmbH
J&P Medical Research Ltd.; Sandoz GmbH

Completed

Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection

Bacterial Infection

Germany, Austria
Hannover Medical School
Biotest

Recruiting

Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins (HBIG)

Chronic Hepatitis B

Germany
University Hospital Tuebingen
University Hospital Muenster; RWTH Aachen University; University Hospital Freiburg

Withdrawn

Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID) (ECMO-VID)

COVID-19 | ARDS, Human

Germany
Dr. Frank Behrens
Bionorica SE

Recruiting

Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19 (BroVID)

COVID-19

Germany
Basilea Pharmaceutica

Terminated

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds (AEGIS)

Invasive Fungal Infections

Israel, Germany, United States, Belgium
University of Cologne

Unknown

MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation (MicroTrans)

Clostridium Infections

Germany
B. Braun Melsungen AG

Completed

Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)

Covid19

Germany
Objectif Recherche Vaccins SIDA

Completed

Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients (MANON 02)

HIV Infection

United States, France, Germany, Spain
Hoffmann-La Roche

Completed

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Hepatitis B, Chronic

Germany
Solvay Pharmaceuticals

Withdrawn

Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Healthy Volunteers

Germany
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Geneva; Wellcome Trust; KEMRI-Wellcome Trust Collaborative... and other collaborators

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

Hemorrhagic Fever, Ebola

Germany
IHF GmbH - Institut für Herzinfarktforschung
Ministerium für Soziales, Arbeit, Gesundheit und Demografie des Landes Rheinland-Pfalz

Completed

COVID-19 Registry Rhineland-Palatinate (Germany)

COVID

Germany
Novartis Vaccines

Completed

Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above

Human Influenza

Germany
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C123 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents Efavirenz and Raltegravir

Hepatitis C Virus

Germany
AbbVie

Terminated

A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA) (Treat & Train)

Axial Spondyloarthritis

Germany
Enanta Pharmaceuticals, Inc

Completed

Two-way Interaction Between Alisporivir and EDP239

Hepatitis C Virus

Germany
InGef - Institute for Applied Health Research Berlin...
BARMER; Robert Koch Institut; Techniker Krankenkasse; DAK Gesundheit; AOK PLUS; IKK... and other collaborators

Completed

Incidence of Diabetes After a COVID-19 Infection (POINTED_Diab)

COVID-19 | Diabetes Mellitus

Germany
Abbott Biologicals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season

Prophylaxis of Influenza

Germany
University Hospital Tuebingen

Withdrawn

Test and Treat COVID 65plus+ (COVID65plus)

COVID-19 | SARS-CoV 2

Germany
University Hospital of Cologne
Clinic for Internal Medicine I, University Hospital Cologne, Germany; Institute... and other collaborators

Unknown

Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults

COVID-19 | SARS-CoV-2

Germany
Hannover Medical School

Completed

Colistin Pharmacokinetics in Critically Ill Patients During Extended Dialysis

Acute Kidney Injury | Infection Due to Resistant Bacteria

Germany
Novartis Vaccines
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine

Hepatitis B | Hepatitis A | Meningococcal Disease | Meningococcal Meningitis

Germany
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008

Seasonal Influenza | Vaccine

Germany
Bionor Immuno AS

Completed

Re-boosting of HIV-1 Infected Subjects With Vacc-4x (Re-boost)

HIV-1 Infection

United States, Spain, Germany, Italy, United Kingdom
Novartis Vaccines

Completed

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

Seasonal Influenza, Vaccine

Germany
Janssen Vaccines & Prevention B.V.

Completed

A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Respiratory Syncytial Virus Infection Prevention

Germany, Spain, Belgium, Sweden, United States
Hoffmann-La Roche

Completed

An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C

Hepatitis C, Chronic

Germany

3

Subscribe